Trial Profile

A phase 3 pivotal trial assessing pegsitacianine to aid in tumor detection of peritoneal carcinomatosis

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 28 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pegsitacianine (Primary)
Indications Carcinoma; Peritoneal cancer
Focus Diagnostic use; Registrational
Sponsors OncoNano Medicine

Most Recent Events

28 Oct 2021 New trial record
25 Oct 2021 According to OncoNano Medicine media release, the Cancer Prevention and Research Institute of Texas (CPRIT) will convert $18.4 million in grant award funding into an equity investment in OncoNano. Proceeds of the financing will be used to support this trial

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com